Johnson & Johnson
NYSE: JNJ
$142.27
-$3.96 (-2.7%)
Closing Price on January 8, 2025
JNJ Articles
Here are previews of five companies set to report quarterly results late Monday or early Tuesday, including IBM and Johnson & Johnson.
Published:
Given the market's nervousness, Stifel's strategy now is to go with defensive value stocks and selected growth stocks. These nine top picks fit the bill, as they are Buy-rated across Wall Street and...
Published:
With the potential for a sizable correction looming, 24/7 Wall St. thought it would be a good idea to look for Dividend Aristocrats that are in defensive sectors but look poised to do well the rest...
Published:
These five top companies are expected to lift the dividends they pay to shareholders this week, making their stocks good total return candidates.
Published:
Markets are closed Friday, so this earnings preview looks ahead to four companies reporting results before markets open on Tuesday.
Published:
With even moderate appreciation in these five safe Dividend King stocks, growth and income investors should be looking at double-digit total return potential. Given the current turmoil in the...
Published:
With the potential for a sizable correction looming, here are five Dividend Aristocrats that are in sectors that are defensive and that are poised to do well the rest of 2022. With even moderate...
Published:
Analysts at Jefferies have a dividend playbook for the rest of 2022. They consider these eight blue-chip stock picks in a variety of sectors to have "rock solid" dividends that are unlikely to be cut...
Published:
Wednesday afternoon's top analyst upgrades and downgrades included Acadia Pharmaceuticals, Constellation Energy, Edwards Lifesciences, Host Hotels & Resorts, Johnson & Johnson and Magna International.
Published:
With the interest rates about to begin increasing, the Nasdaq close to bear market territory and the market starting to anticipate recession, it may be a good idea for investors to consider these...
Published:
Thursday's top analyst upgrades and downgrades included Abbott Laboratories, Antero Midstream, C3.ai, Equitrans Midstream, Hewlett Packard Enterprise, iQIYI, Johnson & Johnson, Opendoor Technologies,...
Published:
With the potential for a sizable correction looming and interest rates soon headed higher, it might be a good idea for investors to Dividend Aristocrats in sectors that are defensive but look poised...
Published:
Here are previews of four companies, including three Dow components, set to report earnings Tuesday morning.
Published:
Wednesday afternoon's top analyst upgrades and downgrades included Advanced Micro Devices, Analog Devices, Applied Materials, Comcast, Chipotle Mexican Grill, Grab, IBM, Johnson & Johnson, Lyft,...
Published:
Now is the time to reduce risk and more to safer ideas. Top-quality health care stocks may be the way to go for the rest of 2021 and in 2022, and these five Dividend Aristocrats make good sense now...
Published:
Last Updated:
Our expert who first called NVIDIA in 2009 is predicting 2025 will see a historic AI breakthrough.
You can follow him investing $500,000 of his own money on our top AI stocks for free.